Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy

Stephen B. Heitner, Katherine L. Fischer

    Research output: Contribution to journalReview articlepeer-review

    2 Scopus citations


    Hypertrophic cardiomyopathy is a heterogenous condition associated with a myriad of symptoms. Just as in other disease states, the aim of medical therapy is the alleviation of suffering, improvement of longevity, and the prevention of complications. This article focuses on the associated comorbidities seen in patients with hypertrophic cardiomyopathy, potential lifestyle interventions, and conventional medical treatments for symptomatic hypertrophic cardiomyopathy.

    Original languageEnglish (US)
    Pages (from-to)45-54
    Number of pages10
    JournalCardiology Clinics
    Issue number1
    StatePublished - Feb 2019


    • Beta-blocker
    • Calcium channel blocker
    • Cardiomyopathy
    • Disopyramide
    • Hypertrophic
    • Lifestyle
    • Obstruction
    • Ranolizine

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine


    Dive into the research topics of 'Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy'. Together they form a unique fingerprint.

    Cite this